FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - GALLBLADDER





FORM # 785-1-027

 CLIN  PATH  DEFINITIONS
     PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

Tis Carcinoma in situ:

T1 Tumor invades mucosa or muscle layer

  T1a Tumor invades mucosa

  T1b Tumor invades muscle layer

T2 Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver

T3 Tumor perforates (visceral peritoneum) or directly invades into one adjacent organ, or both (extension 2 cm or less into liver)

T4 Tumor extends more than 2 cm into liver, and/or into two or more adjacent organs (stomach, duodenum, colon, pancreas, omentum, extrahepatic bile ducts, any involvement of liver)
     LYMPH NODES (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Metastasis in cystic duct, pericholedochal, and/or hilar lymph nodes, i.e., in hepatoduodenal ligament

N2 Metastasis in peripancreatic (head only), periduodena, periportal, celiac, and/or superior mesenteric lymph nodes
     DISTANT METASTASIS (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:  

 CLIN  PATH  STAGE GROUPING

0 Tis N0 M0

I T1 N0 M0

II T2 N0 M0

III T1 N1 M0
      T2 N1 M0
      T3 N0 M0
      T3 N1 M0

IVA T4 N0 M0
      T4 N1 M0

IVB Any T N2 M0
      Any T Any N M1

Stage Grouping by: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:
Patient Name: